Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
Authors
Keywords
-
Journal
Vaccines
Volume 7, Issue 4, Pages 169
Publisher
MDPI AG
Online
2019-11-02
DOI
10.3390/vaccines7040169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities
- (2019) Breanna Hodgins et al. PLoS One
- The Role of M2e in the Development of Universal Influenza Vaccines
- (2019) Xavier Saelens JOURNAL OF INFECTIOUS DISEASES
- Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape
- (2018) Sarah F Andrews et al. CURRENT OPINION IN IMMUNOLOGY
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
- (2018) A Danielle Iuliano et al. LANCET
- Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine
- (2018) Catharine I. Paules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts
- (2018) Irina Tutykhina et al. PLoS One
- Protection by universal influenza vaccine is mediated by memory CD4 T cells
- (2018) Sophie A. Valkenburg et al. VACCINE
- Protective effect of a polyvalent influenza DNA vaccine in pigs
- (2018) Ingrid Karlsson et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model
- (2018) José Herrera-Rodriguez et al. VIROLOGY
- H1N1 influenza virus epitopes classified by monoclonal antibodies
- (2018) Chunyan Guo et al. Experimental and Therapeutic Medicine
- Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
- (2018) Lei Deng et al. Nature Communications
- Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice
- (2018) Yuan Luo et al. Scientific Reports
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
- (2018) Daniela S. Rajão et al. Frontiers in Microbiology
- A Review of DNA Vaccines Against Influenza
- (2018) Leo Yi Yang Lee et al. Frontiers in Immunology
- Novel Platforms for the Development of a Universal Influenza Vaccine
- (2018) Arun Kumar et al. Frontiers in Immunology
- Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
- (2018) Lisa A. Grohskopf et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
- (2018) Brendan Flannery et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
- (2018) Liudmila M. Tsybalova et al. PLoS One
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Universal influenza vaccines: from viruses to nanoparticles
- (2018) Ye Wang et al. Expert Review of Vaccines
- Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs
- (2018) Santosh Dhakal et al. International Journal of Nanomedicine
- DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
- (2018) Katherine V. Houser et al. PLoS One
- Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans
- (2018) Emma J. Grant et al. Nature Communications
- A Perspective on Nanoparticle Universal Influenza Vaccines
- (2018) Lei Deng et al. ACS Infectious Diseases
- Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
- (2017) Sheena G Sullivan et al. Eurosurveillance
- A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza
- (2017) Tor Kristian Andersen et al. JOURNAL OF VIROLOGY
- Influenza
- (2017) Catharine Paules et al. LANCET
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates
- (2017) Merika T. Koday et al. PLoS One
- Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens
- (2017) Peter Pushko et al. VIROLOGY
- Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
- (2017) Florian Krammer et al. Cold Spring Harbor Perspectives in Biology
- Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
- (2017) Johannes Lutz et al. npj Vaccines
- Towards the knowledge-based design of universal influenza epitope ensemble vaccines
- (2016) Qamar M. Sheikh et al. BIOINFORMATICS
- Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice
- (2016) I-Na Lu et al. Cellular & Molecular Immunology
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
- (2016) Diletta Magini et al. PLoS One
- Human influenza viruses and CD8 + T cell responses
- (2016) Emma J Grant et al. Current Opinion in Virology
- Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
- (2016) Nuriban Valero-Pacheco et al. PLoS One
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs
- (2016) Jagadish Hiremath et al. PLoS One
- Stalking influenza by vaccination with pre-fusion headless HA mini-stem
- (2016) Sophie A. Valkenburg et al. Scientific Reports
- Natural T Cell–mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study
- (2015) Andrew C. Hayward et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
- (2015) Michela Brazzoli et al. JOURNAL OF VIROLOGY
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets
- (2015) S. K. Rosendahl Huber et al. PLoS One
- An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
- (2015) Louis M. Schwartzman et al. mBio
- Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
- (2015) Zhongfang Wang et al. Nature Communications
- H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
- (2015) Hang Xie et al. Scientific Reports
- Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
- (2015) Liudmila A. Stepanova et al. PLoS One
- Immunogen design for HIV-1 and influenza
- (2014) Ujjwal Rathore et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
- (2014) Alicia Rodriguez-Gascon et al. International Journal of Nanomedicine
- Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model
- (2014) G. E. Price et al. JOURNAL OF VIROLOGY
- A Viable Recombinant Rhabdovirus Lacking Its Glycoprotein Gene and Expressing Influenza Virus Hemagglutinin and Neuraminidase Is a Potent Influenza Vaccine
- (2014) Alex B. Ryder et al. JOURNAL OF VIROLOGY
- Biomaterials for Nanoparticle Vaccine Delivery Systems
- (2014) Preety Sahdev et al. PHARMACEUTICAL RESEARCH
- Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
- (2014) Danuta M. Skowronski et al. PLoS One
- Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities
- (2014) S. Quinones-Parra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity
- (2014) Min-Chul Kim et al. VACCINE
- Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
- (2014) Jacob Atsmon et al. VACCINE
- Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge
- (2013) Xiao Gao et al. ANTIVIRAL RESEARCH
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Virus-like particles produced in plants as potential vaccines
- (2013) Nunzia Scotti et al. Expert Review of Vaccines
- Improved Method for Linear B-Cell Epitope Prediction Using Antigen’s Primary Sequence
- (2013) Harinder Singh et al. PLoS One
- Cross-reactive human B cell and T cell epitopes between influenza A and B viruses
- (2013) Masanori Terajima et al. Virology Journal
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine
- (2012) Jacob Atsmon et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
- (2012) Glendie Marcelin et al. REVIEWS IN MEDICAL VIROLOGY
- Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza
- (2012) Dan Zheng et al. Viruses-Basel
- Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses
- (2011) Shixia Wang et al. PLoS One
- Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs
- (2011) Hyun-Mi Pyo et al. VACCINE
- Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by -Irradiated Influenza A Viruses
- (2010) Y. Furuya et al. JOURNAL OF VIROLOGY
- Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
- (2010) Emily M. Plummer et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice
- (2009) L. L. M. Poon et al. JOURNAL OF IMMUNOLOGY
- Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections
- (2009) Mohammed Alsharifi et al. PLoS One
- Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice
- (2009) Jeff Alexander et al. VACCINE
- FluBlok, a recombinant hemagglutinin influenza vaccine
- (2008) Manon M.J. Cox et al. Influenza and Other Respiratory Viruses
- Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals
- (2008) Laurel Yong-Hwa Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans
- (2008) E. Assarsson et al. JOURNAL OF VIROLOGY
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started